"Stage II colon cancer" trang 1 - tải miễn phí từ tailieunhanh
RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patients

RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patients
13    71    1
Programmed Death Ligand-1 expression in stage II colon cancer - experiences from a nationwide populationbased cohort

Programmed Death Ligand-1 expression in stage II colon cancer - experiences from a nationwide populationbased cohort
9    52    1
A comparison of 12-gene colon cancer assay gene expression in African American and Caucasian patients with stage II colon cancer

A comparison of 12-gene colon cancer assay gene expression in African American and Caucasian patients with stage II colon cancer
7    49    1
Predictors of recurrence free survival for patients with stage II and III colon cancer

Predictors of recurrence free survival for patients with stage II and III colon cancer
7    51    1
Effects of deficient mismatch repair on the prognosis of patients with stage II and stage III colon cancer during different postoperative periods

Effects of deficient mismatch repair on the prognosis of patients with stage II and stage III colon cancer during different postoperative periods
12    8    1
Benefit of adjuvant chemotherapy in patients with T4 UICC II colon cancer

Benefit of adjuvant chemotherapy in patients with T4 UICC II colon cancer
9    46    1
Impact of age on the use of adjuvant treatments in patients undergoing surgery for colorectal cancer: Patients with stage III colon or stage II/III rectal cancer

Impact of age on the use of adjuvant treatments in patients undergoing surgery for colorectal cancer: Patients with stage III colon or stage II/III rectal cancer
15    64    0
The association between post-treatment surveillance testing and survival in stage II and III colon cancer patients: An observational comparative effectiveness study

The association between post-treatment surveillance testing and survival in stage II and III colon cancer patients: An observational comparative effectiveness study
11    66    0
Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer (MEDOCC-CrEATE): Study protocol for a trial within a cohort study

Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer (MEDOCC-CrEATE): Study protocol for a trial within a cohort study
10    30    1
Isolated tumor cells in stage I & II colon cancer patients are associated with significantly worse disease-free and overall survival

Isolated tumor cells in stage I & II colon cancer patients are associated with significantly worse disease-free and overall survival
7    51    1
1p36 deletion is a marker for tumour dissemination in microsatellite stable stage II-III colon cancer

1p36 deletion is a marker for tumour dissemination in microsatellite stable stage II-III colon cancer
9    50    1
Association of chemotherapy with survival in stage II colon cancer patients who received radical surgery: A retrospective cohort study

Association of chemotherapy with survival in stage II colon cancer patients who received radical surgery: A retrospective cohort study
11    47    1
Prospective observational study of the efficacy of oral uracil and tegafur plus leucovorin for stage II colon cancer with risk factors for recurrence using propensity score matching (JFMC46-1201)

Prospective observational study of the efficacy of oral uracil and tegafur plus leucovorin for stage II colon cancer with risk factors for recurrence using propensity score matching (JFMC46-1201)
10    16    1
KCNQ1 and lymphovascular invasion are key features in a prognostic classifier for stage II and III colon cancer

KCNQ1 and lymphovascular invasion are key features in a prognostic classifier for stage II and III colon cancer
8    20    1
Interaction analysis of high-risk pathological features on adjuvant chemotherapy survival benefit in stage II colon cancer patients: A multi-center, retrospective study

Interaction analysis of high-risk pathological features on adjuvant chemotherapy survival benefit in stage II colon cancer patients: A multi-center, retrospective study
12    1    1
CTCs as a prognostic and predictive biomarker for stage II/III Colon Cancer: A companion study to the PePiTA trial

CTCs as a prognostic and predictive biomarker for stage II/III Colon Cancer: A companion study to the PePiTA trial
7    57    0
Báo cáo y học:

Báo cáo y học: "Evaluation of lymph node numbers for adequate staging of Stage II and III colon cancer"
9    55    0